Nonetheless, up-regulation was significant in Lactoferrin loaded-CIS and Titanium loaded-CIS with 0.75&0.6 fold changes respectively, reflecting Lac-CIS regimen superiority. The gene discussed is LCT; the disease is in situ carcinoma.